NASDAQ : AARD

Aardvark Therapeutics, Inc. Common Stock

$5.86 USD

-$0.47 (-7.42%)

Volume
218.32K
Average Volume
269.55K
Market Capitalization
$128.24M
P/E Ratio
-1.83
Dividend Yield
0.00%
Price Target
$4.50
Year High
$17.94
Year Low
$3.35
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$8.06
3333332"{? p/.m7yd f,0=

Annual earnings financials

AARD financial data with annual/quarterly toggle

AARD GAAP EPS - Annual & Quarterly

AARD Sales Revenue - Annual & Quarterly

AARD Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

AARD Estimated and Actual Revenue by Quarter
AARD Estimated and Actual EPS by Quarter
AARD Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 1 - - - - - -
2028-09-30 1 - - - - - -
2028-06-30 1 - - - - - -
2028-03-31 0 - - - - - -
2027-12-31 0 - - - - - -
2027-09-30 0 - - - - - -
AARD Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 1 -44.8M -44.8M -44.8M - - -
2028-09-30 1 -36.01M -36.01M -36.01M - - -
2028-06-30 1 -26.11M -26.11M -26.11M - - -
2028-03-31 0 -21.24M -21.24M -21.24M - - -
2027-12-31 0 -19.28M -19.28M -19.28M - - -
2027-09-30 0 -19.16M -19.16M -19.16M - - -
AARD Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 1 51.18M 51.18M 51.18M 5 -2.0535 -2.0535 -2.0535
2028-09-30 1 34.36M 34.36M 34.36M 5 -1.6507 -1.6507 -1.6507
2028-06-30 1 14.72M 14.72M 14.72M 6 -1.197 -1.197 -1.197
2028-03-31 0 - - - 3 -0.9736 -0.9736 -0.9736
2027-12-31 0 - - - 2 -0.8839 -0.8839 -0.8839
2027-09-30 0 - - - 2 -0.8784 -0.8784 -0.8784